Carnegie appeared to be the Corporate Investor, which was created in 1803. The fund was located in Europe if to be more exact in Sweden. The leading representative office of defined Corporate Investor is situated in the Stockholm.
Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Corus Pharma. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most successful fund investment fields, there are Pharmaceutical, Biotechnology.
The usual cause for the fund is to invest in rounds with 6 partakers. Despite the Carnegie, startups are often financed by Kleiner Perkins, JPMorgan Partners (JPMP), Chrysalix Venture Capital. The meaningful sponsors for the fund in investment in the same round are WestRiver Group, LLC, Washington State University, SunAmerica Ventures.
The important activity for fund was in 2004. The higher amount of exits for fund were in 2006. The real fund results show that this Corporate Investor is 13 percentage points more often commits exit comparing to other companies. Opposing the other organizations, this Carnegie works on 4 percentage points more the average amount of lead investments. The fund is generally included in less than 2 deals every year. The usual things for fund are deals in the range of 10 - 50 millions dollars. When the investment is from Carnegie the average startup value is 50-100 millions dollars.
Fund Name | Location |
10,000 Start-Ups | India, Noida, Uttar Pradesh |
Amnis Ventures | Houston, Texas, United States |
Ascend Venture Capital | Missouri, Saint Louis, United States |
Bonaventure Capital | Alabama, Birmingham, United States |
BrainLAB | Bayern, Germany, Munich |
Denshi-koen | Japan, Tokyo |
Diaspora Angel Network | - |
Givaudan | Geneva, Geneve, Switzerland |
High Park Angels | Canada, Ontario, Toronto |
Kharis Capital | - |
Lapam Capital | Beijing, Beijing, China |
NES Partners | Copenhagen, Denmark, Hovedstaden |
Rally Ventures | California, Menlo Park, United States |
Shanghai Haoyi | China, Shanghai |
Startech Early Ventures | Richardson, Texas, United States |
Startive Ventures | Geneva, Geneve, Switzerland |
WILD Group Management | Switzerland, Zug, Zug |
Wuhan Sanxin Touzi | China, Hubei, Wuhan |
Yongjin Group | China, Shanghai |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Doktor.se | $53M | 27 May 2020 | Stockholm County |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Doktor.se | $53M | 27 May 2020 | Stockholm County |